Liat Nachshon

13PUBLICATIONS
9CO-AUTHORS
Food safety, traceability, certification and authenticityAllergyHorticultural crop protection (incl. pests, diseases and weeds)NeonatologyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 12, 2026
Cashew Reaction Thresholds, Its Predictors, and Very Low Validated Safe Doses, in a Large Allergic Population (Nut CRACKER Study).

|Nov 20, 2025
Decreased Severity of Oral Immunotherapy Induced Gastrointestinal Eosinophilic Reactions Following Revisions in Milk-Treatment Protocol.

Na'ama Epstein-Rigbi, Matan Elkan, Yair Tzarfati

|Aug 22, 2023
Sesame eliciting and safe doses in a large sesame allergic population.

Liat Nachshon, Joost Westerhout, W Marty Blom

|Oct 03, 2022
Efficacy and safety of food allergy oral immunotherapy in adults.

Na'ama Epstein-Rigbi, Michael B Levy, Liat Nachshon

|Jan 09, 2022
Cashew oral immunotherapy for desensitizing cashew-pistachio allergy (NUT CRACKER study).

Arnon Elizur, Michael Y Appel, Liat Nachshon

|Aug 09, 2021
Safe administration of the Pfizer-BioNtTech COVID-19 vaccine following an immediate reaction to the first dose.

Aharon Kessel, Ellen Bamberger, Liat Nachshon

Pageof 3

Frequent Collaborators

9 joint publications

Michael R Goldberg

8 joint publications

Arnon Elizur

8 joint publications

Naama Epstein-Rigby

1 joint publications

Michael Y Appel